Evicenter
P&T meetings

Zeleciment rostudirsen (z-rostudirsen)

Duchenne muscular dystrophy

Also known as DYNE-251
Manufacturer
Dyne Therapeutics
Regulatory submission
BLA submitted May 2026
Last updated
78 sources

Product information and disease descriptionProduct descriptionProduct information

Dosage forms and strengths

1 evidence topic · 1 source

Investigational formulation and recorded strengths
Registry fieldQuoted record
Pharmaceutical form“Solution for infusion”
First recorded strength, mg“200”
Second recorded strength, mg“350”
Commercial formulation, packaging, and storage requirements

No evidence found.

Material safety data sheet

No evidence found.